Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213103742> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4213103742 endingPage "611" @default.
- W4213103742 startingPage "607" @default.
- W4213103742 abstract "A subgroup of myasthenia gravis (MG) patients fail to respond adequately to recommended treatments, a condition referred to as refractory MG. During the refractory phase, patients experience persistent debilitating symptoms with potential life-threatening events or inability to reduce immunosuppressant dosages and minimize long-term toxicities.We conducted a retrospective, single-center study of 113 MG patients to investigate the autoantibody profile and clinical characteristics of refractory MG patients, compared with nonrefractory patients, based on predefined criteria.Fifteen patients (13.3%) were classified as refractory. Double-seronegative MG (DSNMG), without detectable nicotinic acetylcholine receptor (AChR) or muscle-specific tyrosine kinase (MuSK) antibodies, was identified in six refractory patients, significantly higher than those with nonrefractory MG (40% vs 16.3%; P = .031). None of the refractory patients had MuSK antibodies. Patients in the refractory group more frequently had an earlier disease onset, thymic pathology, and thymectomy (P ≤. 03 for all).In this study, patients with refractory MG were more likely than those with nonrefractory MG to be DSN; and refractory DSNMG patients had worse MGFA classes in their recent visit compared with anti-AChR positive refractory patients. Refractory DSNMG patients may represent a distinct group that requires more individualized and targeted treatment approaches." @default.
- W4213103742 created "2022-02-24" @default.
- W4213103742 creator A5000414294 @default.
- W4213103742 creator A5025660802 @default.
- W4213103742 creator A5039929936 @default.
- W4213103742 creator A5062391542 @default.
- W4213103742 date "2022-03-09" @default.
- W4213103742 modified "2023-10-16" @default.
- W4213103742 title "Autoantibody profile in myasthenia gravis patients with a refractory phase" @default.
- W4213103742 cites W2065357689 @default.
- W4213103742 cites W2109351747 @default.
- W4213103742 cites W2406546229 @default.
- W4213103742 cites W2461303519 @default.
- W4213103742 cites W2545074962 @default.
- W4213103742 cites W2586254189 @default.
- W4213103742 cites W2742758273 @default.
- W4213103742 cites W2789644345 @default.
- W4213103742 cites W2919659424 @default.
- W4213103742 cites W2995776730 @default.
- W4213103742 cites W3029624457 @default.
- W4213103742 cites W3094785429 @default.
- W4213103742 cites W3113158782 @default.
- W4213103742 cites W3113255181 @default.
- W4213103742 doi "https://doi.org/10.1002/mus.27521" @default.
- W4213103742 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35195920" @default.
- W4213103742 hasPublicationYear "2022" @default.
- W4213103742 type Work @default.
- W4213103742 citedByCount "3" @default.
- W4213103742 countsByYear W42131037422022 @default.
- W4213103742 countsByYear W42131037422023 @default.
- W4213103742 crossrefType "journal-article" @default.
- W4213103742 hasAuthorship W4213103742A5000414294 @default.
- W4213103742 hasAuthorship W4213103742A5025660802 @default.
- W4213103742 hasAuthorship W4213103742A5039929936 @default.
- W4213103742 hasAuthorship W4213103742A5062391542 @default.
- W4213103742 hasConcept C121332964 @default.
- W4213103742 hasConcept C126322002 @default.
- W4213103742 hasConcept C142424586 @default.
- W4213103742 hasConcept C159654299 @default.
- W4213103742 hasConcept C163764329 @default.
- W4213103742 hasConcept C203014093 @default.
- W4213103742 hasConcept C2778105408 @default.
- W4213103742 hasConcept C2779615886 @default.
- W4213103742 hasConcept C71924100 @default.
- W4213103742 hasConcept C87355193 @default.
- W4213103742 hasConcept C90924648 @default.
- W4213103742 hasConceptScore W4213103742C121332964 @default.
- W4213103742 hasConceptScore W4213103742C126322002 @default.
- W4213103742 hasConceptScore W4213103742C142424586 @default.
- W4213103742 hasConceptScore W4213103742C159654299 @default.
- W4213103742 hasConceptScore W4213103742C163764329 @default.
- W4213103742 hasConceptScore W4213103742C203014093 @default.
- W4213103742 hasConceptScore W4213103742C2778105408 @default.
- W4213103742 hasConceptScore W4213103742C2779615886 @default.
- W4213103742 hasConceptScore W4213103742C71924100 @default.
- W4213103742 hasConceptScore W4213103742C87355193 @default.
- W4213103742 hasConceptScore W4213103742C90924648 @default.
- W4213103742 hasIssue "5" @default.
- W4213103742 hasLocation W42131037421 @default.
- W4213103742 hasLocation W42131037422 @default.
- W4213103742 hasOpenAccess W4213103742 @default.
- W4213103742 hasPrimaryLocation W42131037421 @default.
- W4213103742 hasRelatedWork W2080850932 @default.
- W4213103742 hasRelatedWork W2156388404 @default.
- W4213103742 hasRelatedWork W2250964896 @default.
- W4213103742 hasRelatedWork W2336228367 @default.
- W4213103742 hasRelatedWork W2416131104 @default.
- W4213103742 hasRelatedWork W3025030573 @default.
- W4213103742 hasRelatedWork W3088289473 @default.
- W4213103742 hasRelatedWork W3095962444 @default.
- W4213103742 hasRelatedWork W4242042224 @default.
- W4213103742 hasRelatedWork W4285524673 @default.
- W4213103742 hasVolume "65" @default.
- W4213103742 isParatext "false" @default.
- W4213103742 isRetracted "false" @default.
- W4213103742 workType "article" @default.